Health Kick Podcast: The science behind 2019’s hottest IPO and the company’s plans for 2020
Health & Biotech
Health & Biotech
Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast.
In this episode Tim chats with Osteopore (ASX:OSX) executive director Geoff Pocock.
Osteopore is a developer of bioresorbable bone healing implants that dissolve over time, leaving only healthy bone tissue.
Made using 3D techniques, Osteopore’s implants are a natural alternative to bone grafts or metallic implants such as titanium.
The company had a monumental debut on the ASX, jumping a whopping 300 per cent above its 63c IPO price.
So tune in to hear the pair discuss Osteopore’s game changing tech, deals in China and plans for 2020.
On mobile? Click here to listen with Apple podcasts, here for Spotify or here for Google Podcasts.
Like to listen to podcasts through another app? Just search for The Health Kick Podcast with Tim Boreham and subscribe!